DISSEMINATED NOCARDIOSIS DUE TO NOCARDIA SPECIES.
- Head of Department of critical care MD, PhD. TSMU the First University Clinic (Tbilisi, Georgia). \ Microbiologist. MD. PhD.TSMU the First University Clinic (Tbilisi, Georgia).
- Head of Clinical Laboratory. MD. PhD.TSMU the First University Clinic (Tbilisi, Georgia).
- Laboratory Phisician, TSMU the First University Clinic(Tbilissi, Georgia).
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Nocardiosis is a vital, but often ignored, infectious disease in immunocompromised hosts, which is particularly serious in the absence of timely diagnosis and therapy. Nocardiosis affects patients who display a cellular immunodeficiency, such as transplant recipients on immunosuppressive treatment, but uncommonly associated with high morbidity and mortality rates. Disseminated Nocardiosis affecting the central nervous system (CNS), abdomen, skin and lungs .Nocardia spp. infection can be observed and confirmed by subculture and positive microscopic detection of a branching gram-positive rod. Infection commonly enters via the respiratory route but may also occur through skin trauma. A case of disseminated nocardiosis in an immunocompetent individual after car accident is presented. The case highlights challenges surrounding diagnosis and microbiological identification of Gram-positive branching bacilli, patient management, and choice of antibiotic.
- McNeil M.M., Brown J.M. The medically important aerobic actinomycetes: epidemiology and microbiology.ClinMicrobiol Rev.?1994;7(3):357?417
- Young L.S., Rubin R.H. Mycobacterial and nocardial diseases in the compromised host. In: Rubin R.H., Young L.S., editors.A Clinical Approach to Infection in the Compromised Host.?4th ed. Kluwer Academic; New York, NY: 2002. pp. 257?261.
- Martinez R., Reyes S., Menendez R. Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis.CurrOpinPulm Med.?2008;14(3):219?227.?[PubMed]
- Kontoyiannis D.P., Jacobson K.L., Whimbey E.E., Rolston K.V., Raad I.I. Central venous catheter-associatedNocardia?bacteremia: an unusual manifestation of nocardiosis.?Clin Infect Dis.?2000;31(2):617?618.?[PubMed]
- Munoz J., Mirelis B., Aragon L.M. Clinical and microbiological features of nocardiosis 1997-2003.J Med Microbiol.?2007;56(pt 4):545?550.?[PubMed]
- Gombert M.E., Berkowitz L.B., Aulicino T.M., duBouchet L. Therapy of pulmonary nocardiosis in immunocompromised mice.Antimicrob Agents Chemother.?1990;34(9):1766?1768.?[PMC free article][PubMed]
- McNeil M.M., Brown J.M., Hutwagner L.C., Schiff T.A. Evaluation of therapy forNocardiaasteroides?complex infecton: CDN/NCID report.?Infect Dis ClinPract.?1995;4(4):287?292.
- McNeil M.M., Brown J.M. The medically important aerobic actinomycetes: epidemiology and microbiology.ClinMicrobiol Rev.?1994;7(3):357?417
[Guliko Kiliptari, Tamar Didbaridze, Nino Gogokhia and Khatia Mikaberidze. (2017); DISSEMINATED NOCARDIOSIS DUE TO NOCARDIA SPECIES. Int. J. of Adv. Res. 5 (Apr). 282-285] (ISSN 2320-5407). www.journalijar.com
